BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2718530)

  • 1. [TSH receptor antibody determination using the TSH radioreceptor antibody assay in clinical practice].
    Hampel R; Männchen E; Meng S; Meng W
    Z Gesamte Inn Med; 1989 Feb; 44(4):113-6. PubMed ID: 2718530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation.
    Schott M; Feldkamp J; Bathan C; Fritzen R; Scherbaum WA; Seissler J
    Horm Metab Res; 2000 Oct; 32(10):429-35. PubMed ID: 11069209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of thyrostatic treatment on circulating thyrotropin-receptor antibodies in Basedow's disease].
    Lozanov B; Kirilov G; Ivanova R; Khubaveshki S
    Vutr Boles; 1990; 29(3):79-84. PubMed ID: 1704667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical role of TSH binding inhibiting antibodies (TBIAb) assay.
    Rubello D; Girelli ME; Piccolo M; Franzelin F; Betterle C; Busnardo B
    J Nucl Med Allied Sci; 1990; 34(1):29-33. PubMed ID: 2384822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial.
    Schott M; Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; Golla R; Graeber C; van Helden J; Inomata K; Jarausch J; Kratzsch J; Miyazaki N; Moreno MA; Murakami T; Roth HJ; Stock W; Noh JY; Scherbaum WA; Mann K
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etiology and pathogenesis of autoimmune diseases of the thyroid gland].
    Schleusener H; Bogner U; Schwander J; Kotulla P; Finke R
    Z Gesamte Inn Med; 1988 Mar; 43(6):133-9. PubMed ID: 3291425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Techniques to quantify TSH receptor antibodies.
    Ajjan RA; Weetman AP
    Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):461-8. PubMed ID: 18574503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of the determination of TSH-binding inhibitory immunoglobulins (TBII) by a radioreceptor assay].
    Heberling HJ; Bierwolf B; Lohmann D
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(5):301-6. PubMed ID: 2879721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy].
    Heberling HJ; Bierwolf B; Kuhlmann E; Klugmann T; Dietel P; Fischer S
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):331-6. PubMed ID: 2896115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease].
    Zöphel K; Wunderlich G; Koch R; Franke WG
    Nuklearmedizin; 2000; 39(4):113-20. PubMed ID: 10919162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of thyroid antibodies].
    Toldy E; Lócsei Z; Kalmár I; Varga L; Kovács LG
    Orv Hetil; 1996 Sep; 137(38):2075-80. PubMed ID: 8966023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thyroid function tests].
    Uchimura H
    Rinsho Byori; 2001 Apr; 49(4):319-24. PubMed ID: 11391943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypothyroidism and endocrine orbitopathy].
    Wiesli P; Knierim M; Knierim C; Schmid C
    Praxis (Bern 1994); 2000 Oct; 89(40):1612-5. PubMed ID: 11081360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of TSH receptor antibody determination].
    Gannage MH; Haddad F; Jambart S; Atallah C; Halaby G
    J Med Liban; 1996; 44(3):134-7. PubMed ID: 9296963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [99mTc uptake and TSH receptor autoantibodies--comparative study in Basedow's disease and other thyroid diseases].
    Baum RP; Happ J; Maul FD; Standke R; Hör G
    Nuklearmedizin; 1985 Jun; 24(3):141-5. PubMed ID: 2997753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of determination of antibodies to TSH receptors (using TRAK) in the diagnosis and monitoring of therapy in endocrine orbital disease].
    Vána S; Nĕmec J; Rezek P; Sterzl I; Bílek R; Novák Z
    Vnitr Lek; 1994 Oct; 40(10):636-8. PubMed ID: 7810080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.